IT1403584B1 - Uso di inibitori della pteridina reduttasi per la prevenzione e/o il trattamento di infezioni parassitarie - Google Patents
Uso di inibitori della pteridina reduttasi per la prevenzione e/o il trattamento di infezioni parassitarieInfo
- Publication number
- IT1403584B1 IT1403584B1 ITMI2010A002191A ITMI20102191A IT1403584B1 IT 1403584 B1 IT1403584 B1 IT 1403584B1 IT MI2010A002191 A ITMI2010A002191 A IT MI2010A002191A IT MI20102191 A ITMI20102191 A IT MI20102191A IT 1403584 B1 IT1403584 B1 IT 1403584B1
- Authority
- IT
- Italy
- Prior art keywords
- pteridine
- prevention
- treatment
- parasitic infections
- inhibitors reduced
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/433—Thidiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/428—Thiazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITMI2010A002191A IT1403584B1 (it) | 2010-11-25 | 2010-11-25 | Uso di inibitori della pteridina reduttasi per la prevenzione e/o il trattamento di infezioni parassitarie |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITMI2010A002191A IT1403584B1 (it) | 2010-11-25 | 2010-11-25 | Uso di inibitori della pteridina reduttasi per la prevenzione e/o il trattamento di infezioni parassitarie |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ITMI20102191A1 ITMI20102191A1 (it) | 2012-05-26 |
| IT1403584B1 true IT1403584B1 (it) | 2013-10-31 |
Family
ID=43742803
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ITMI2010A002191A IT1403584B1 (it) | 2010-11-25 | 2010-11-25 | Uso di inibitori della pteridina reduttasi per la prevenzione e/o il trattamento di infezioni parassitarie |
Country Status (1)
| Country | Link |
|---|---|
| IT (1) | IT1403584B1 (it) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3842174A (en) * | 1966-12-23 | 1974-10-15 | American Cyanamid Co | Substituted nitroimidazolylthiadiazoles and oxadiazoles as antiprotozoal agents |
| JP2010529194A (ja) * | 2007-06-13 | 2010-08-26 | ノースイースタン・ユニバーシティ | 抗生物質 |
| WO2010108187A2 (en) * | 2009-03-20 | 2010-09-23 | Brandeis University | Compounds and methods for treating mammalian gastrointestinal microbial infections |
-
2010
- 2010-11-25 IT ITMI2010A002191A patent/IT1403584B1/it active
Also Published As
| Publication number | Publication date |
|---|---|
| ITMI20102191A1 (it) | 2012-05-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SMT201600021B (it) | Nuovi composti di chinolina sostituiti come inibitori della s-nitrosoglutatione reduttasi | |
| SMT201600278B (it) | Inibitori della benzossazolo chinasi e metodi d'uso | |
| SMT201600135B (it) | Nuovi inibitori della s-nitrosoglutatione riduttasi | |
| SMT201600003B (it) | Inibitori indazolici della via di segnalazione wnt e loro usi terapeutici | |
| SMT201600238B (it) | Inibitori di protein chinasi | |
| SMT201400148B (it) | Inibitori di jak2 e loro uso per il trattamento del cancro e di malattie mieloproliferative | |
| SMT201500271B (it) | Inibitori di neprilisina | |
| BRPI0807487A2 (pt) | Uso de antagonistas de il-23 para o tratamento de infecção | |
| SMT201600264B (it) | POLIMORFI E SOLVATI DI 4-[-2-[[5-METlL-1-(2-NAFTALENlL)-1H-PIRAZOL-3-IL]OSSl]ETlL]MORFOLINA CLORIDRATO | |
| SMT201500076B (it) | Derivati di chinazolin-4(3H)-one utilizzati come inibitori della PI3 chinasi | |
| SMT201400008B (it) | Uso di betanecolo per il trattamento di xerostomia | |
| BR112012022878A2 (pt) | composto, composição farmacêutica, uso do compostos e método de tratamento | |
| SMT201700056B (it) | Fosfaplatine e relativo utilizzo per il trattamento di cancro | |
| BR112014001991A2 (pt) | certos inibidores de quinurenina-3-monooxigenase, composições farmacêuticas e métodos de uso dos mesmos | |
| BRPI1005670A2 (pt) | composições adjuvantes e métodos de uso | |
| ITTO20110641A1 (it) | Composizioni farmaceutiche e metodi di trattamento | |
| BRPI0911332A2 (pt) | composições e uso de inibidores de epas1 | |
| BR112012001797A2 (pt) | composto bicíclico e uso do mesmo para propósitos médicos | |
| BRPI0922344A2 (pt) | inibidores de tfpi e métodos de uso | |
| SMT201600059B (it) | Trattamento di infezioni da streptococco | |
| BR112012005774B8 (pt) | uso de um inibidor de quinase antiangiogênico no tratamento de câncer | |
| ITMI20121265A1 (it) | Procedimento per la determinazione della grandezza e posizione di oggetti | |
| BR112013010331A2 (pt) | composições adesivas crepadas e métodos de uso dessas composições | |
| BRPI0911469A2 (pt) | inibidores de gm-csf e il-17 para terapia | |
| SMT201400165B (it) | Composizioni e metodi per il trattamento di sclerosi multipla |